Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis.

Gupta, Tejpal; Thakkar, Prafulla; Kalra, Babusha; Kannan, Sadhana

Gupta, Tejpal; Thakkar, Prafulla; Kalra, Babusha; Kannan, Sadhana.

Afiliación

Gupta T; Department of Radiation Oncology, Clinical Research Centre, Advanced Centre for Treatment Research & Education in Cancer (ACTREC), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Kharghar, Navi Mumbai, India.
Thakkar P; Division of Internal Medicine, Clinical Research Centre, Advanced Centre for Treatment Research & Education in Cancer (ACTREC), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Kharghar, Navi Mumbai, India.
Kalra B; Department of Radiation Oncology, Clinical Research Centre, Advanced Centre for Treatment Research & Education in Cancer (ACTREC), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Kharghar, Navi Mumbai, India.
Kannan S; Clinical Research Secretariat, Clinical Research Centre, Advanced Centre for Treatment Research & Education in Cancer (ACTREC), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Kharghar, Navi Mumbai, India.

Rev Med Virol ; 32(2): e2276, 2022 03.

Article en En | MEDLINE | ID: mdl-34245622

Asunto(s)

Tratamiento Farmacológico de COVID-19; Hidroxicloroquina; Humanos; Hidroxicloroquina/efectos adversos; Estudios Prospectivos; SARS-CoV-2

Palabras clave

coronavirus; hydroxychloroquine; toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Rev Med Virol Asunto de la revista: VIROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google